drugset / Trial / NCT01203371

Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS

NCT01203371

Phase 3 Withdrawn Apsen Farmaceutica S.A.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness and safety of Naftopidil and Tamsulosin in the treatment of lower urinary tract symptoms through a comparative study of patients with benign prostatic hyperplasia.

Timeline

Start
2011-01-01
Primary completion
2011-09-01
Completion
2012-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Naftopidil Small molecule 0.5 mg
Comparator Tamsulosin Other / unclassified 0.4 mg

Indications